前列腺癌患者抗阻运动有效性的最小剂量:患者报告结局的系统综述与Meta分析
该系统综述与Meta分析纳入18项随机对照试验共1112名前列腺癌患者,评估抗阻运动对疲劳、生活质量、抑郁和焦虑的最小有效剂量。结果显示抗阻运动显著改善疲劳(效应量=-0.3,95%CI:-0.4至-0.2,P<0.001)和生活质量(效应量=0.2,95%CI:0.0至0.4,P=0.018),对抑郁和焦虑症状改善呈阳性趋势但未达统计学显著。Meta回归未发现运动成分与疲劳和生活质量结局间存在显著关联。
要点
- 低容量、中高强度的抗阻运动足以显著改善前列腺癌患者疲劳和生活质量。
- 抗阻运动对抑郁和焦虑症状有改善趋势但未达统计学显著。
- 低于常规处方的抗阻运动剂量可能通过减少运动障碍来提高依从性。
核心结论
- 低容量中高强度抗阻运动足以显著改善前列腺癌患者疲劳和生活质量,并可能缓解抑郁和焦虑症状。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索MEDLINE、CINAHL、EMBASE、SPORTDiscus和Web of Science数据库,纳入18项随机对照试验共1112名前列腺癌患者。
主要发现
- 抗阻运动对疲劳有显著效应(效应量=-0.3,95%CI:-0.4至-0.2,P<0.001)。
- 抗阻运动对生活质量有显著效应(效应量=0.2,95%CI:0.0至0.4,P=0.018)。
- 抗阻运动对抑郁症状效应为-0.3(95%CI:-0.7至0.0),对焦虑症状效应为-0.3(95%CI:-0.5至0.0),均未达统计学显著(P=0.071至0.077)。
- Meta回归显示抗阻运动成分与疲劳和生活质量结局间无显著关联(P=0.186至0.689)。
临床怎么用
- 前列腺癌患者在接受治疗期间或治疗后,可考虑采用低容量、中高强度的抗阻运动以改善疲劳和生活质量。
- 低于常规处方的抗阻运动剂量可能有助于提高患者依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Active treatments for prostate cancer are well known to result in several adverse effects such as fatigue, depression and anxiety symptoms, impacting the overall quality of life (QoL) and wellbeing of a considerable proportion of patients. Resistance-based exercise interventions have shown positive effects to reduce or mitigate these treatment-related side effects. However, the minimal dosage required to derive these benefits is unknown. We systematically reviewed the resistance training effects in prostate cancer patients to determine the minimal dosage regarding the exercise components (mode, duration, volume and intensity) on fatigue, QoL, depression and anxiety. METHODS: Using PRISMA guidelines, MEDLINE, CINAHL, EMBASE, SPORTDiscus and Web of Science databases were searched. Eligible randomised controlled trials examined prostate cancer patients undertaking resistance-based exercise programs during or following treatment. Meta-analysis was undertaken when more than three studies were included. Associations between resistance exercise components and its effects were tested by meta-regression analysis. RESULTS: Eighteen trials involving 1112 men with prostate cancer were included. Resistance-based exercise programs resulted in significant effects on fatigue (effect size = -0.3, 95% CI: -0.4 to -0.2, P < 0.001) and QoL (effect size = 0.2, 95% CI: 0.0 to 0.4, P = 0.018), with significant effects in specific questionnaires and domains of these outcomes. Resistance-based exercise effects on depression (effect size = -0.3, 95% CI: -0.7 to 0.0) and anxiety symptoms (effect size = -0.3, 95% CI: -0.5 to 0.0) were positive but not significant (P = 0.071 to 0.077). Meta-regression indicated no significant association between resistance exercise components with fatigue and QoL outcomes (P = 0.186-0.689). CONCLUSIONS: Low volume resistance exercise undertaken at a moderate-to-high intensity is sufficient to achieve significant fatigue and QoL benefits for men with prostate cancer and also mitigate depression and anxiety symptoms. A lower resistance exercise dosage than usually prescribed may help enhance adherence by reducing exercise barriers.
引用
- Lopez P, Taaffe DR, Newton RU, et al. What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes. Prostate Cancer Prostatic Dis. 2020. PMID: 33219369. doi:10.1038/s41391-020-00301-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。